{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:09Z","timestamp":1759048089734},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.clim.2006.01.003","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T20:16:15Z","timestamp":1141244175000},"page":"252-260","source":"Crossref","is-referenced-by-count":3,"title":["TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"119","author":[{"given":"Luiz Stark","family":"Aroeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2006.01.003_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.189.7.1033","article-title":"Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"189","author":"Tuohy","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.01.003_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(88)90558-2","article-title":"Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention","volume":"54","author":"Acha-Orbea","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.clim.2006.01.003_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.4049\/jimmunol.146.3.879","article-title":"Identification of encephalitogenic V beta-4-bearing T cells in SJL mice. Further evidence for the V region disease hypothesis?","volume":"146","author":"Padula","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib4","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells","volume":"25","author":"Mendel","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib5","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1073\/pnas.88.20.9161","article-title":"Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis","volume":"88","author":"Kotzin","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.01.003_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/362068a0","article-title":"Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis","volume":"362","author":"Oksenberg","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2006.01.003_bib7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0167-5699(92)90024-2","article-title":"The cognitive paradigm and the immunological homunculus","volume":"13","author":"Cohen","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.clim.2006.01.003_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/eji.1830111119","article-title":"Vaccination against autoimmune encephalomyelitis (EAE): attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line","volume":"11","author":"Ben-Nun","year":"1981","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2447648","article-title":"Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis","volume":"239","author":"Lider","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.clim.2006.01.003_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.autrev.2003.10.002","article-title":"T-cell vaccination in multiple sclerosis: update on clinical application and mode of action","volume":"3","author":"Hellings","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2006.01.003_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08916939908994069","article-title":"Immunoregulation of encephalitogenic MBP-NAc1-11-reactive T cells by CD4+ TCR-specific T cells involves IL-4, IL-10 and IFN-gamma","volume":"31","author":"Adlard","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2006.01.003_bib12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.154.4.1941","article-title":"Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis","volume":"154","author":"Kumar","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib13","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.4049\/jimmunol.170.6.2985","article-title":"Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes","volume":"170","author":"Madakamutil","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib14","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.4049\/jimmunol.161.12.6585","article-title":"Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells","volume":"161","author":"Kumar","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib15","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4049\/jimmunol.149.8.2803","article-title":"Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39\u201359 region of the TCR-V beta 8.2 chain","volume":"149","author":"Hashim","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib16","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.144.12.4621","article-title":"Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis","volume":"144","author":"Hashim","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib17","first-page":"83","article-title":"Antibodies against T-cell receptor peptide arrest autoimmune rejection of normal central nervous system myelin","volume":"23","author":"Hashim","year":"1991","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.clim.2006.01.003_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/jaut.1997.0125","article-title":"Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies","volume":"10","author":"Herkel","year":"1997","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2006.01.003_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0022-2836(92)90455-S","article-title":"Secretion of T cell receptor fragments from recombinant Escherichia coli cells","volume":"224","author":"Ward","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.clim.2006.01.003_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","article-title":"Adjuvants\u2014a classification and review of their modes of action","volume":"15","author":"Cox","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2006.01.003_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.0818-9641.2004.01286.x","article-title":"Aluminium compounds for use in vaccines","volume":"82","author":"Lindblad","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.clim.2006.01.003_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1073\/pnas.83.3.767","article-title":"Murine T-cell receptor mutants with deletions of beta-chain variable region genes","volume":"83","author":"Behlke","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2006.01.003_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clim.2006.01.003_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0950-3579(05)80184-0","article-title":"Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination","volume":"6","author":"Kingsley","year":"1992","journal-title":"Bailliere's Clin. Rheumatol."},{"key":"10.1016\/j.clim.2006.01.003_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1084\/jem.178.3.909","article-title":"The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease","volume":"178","author":"Kumar","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.01.003_bib26","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.159.10.5150","article-title":"Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells","volume":"159","author":"Kumar","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib27","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.160.10.4822","article-title":"A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL\/6 mice and BALB\/c mice","volume":"160","author":"Falcone","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0165-5728(00)00236-8","article-title":"Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach","volume":"107","author":"Martino","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2006.01.003_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0165-5728(98)00166-0","article-title":"Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1","volume":"91","author":"Aharoni","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2006.01.003_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/1074-7613(95)90169-8","article-title":"An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis","volume":"3","author":"Nicholson","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2006.01.003_bib31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/eji.1830210536","article-title":"Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels","volume":"21","author":"Goldschmidt","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib32","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.4049\/jimmunol.165.12.6858","article-title":"Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination","volume":"165","author":"Hong","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI200316039","article-title":"Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis","volume":"112","author":"Jambou","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2006.01.003_bib34","first-page":"181","article-title":"Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy","volume":"49","author":"Jambou","year":"2003","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"key":"10.1016\/j.clim.2006.01.003_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/135245859700300218","article-title":"A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg)","volume":"3","author":"Pashov","year":"1997","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clim.2006.01.003_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1381612033392152","article-title":"Regulation of self-reactive T cells by human immunoglobulins\u2014Implications for multiple sclerosis therapy","volume":"9","author":"Aktas","year":"2003","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.clim.2006.01.003_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-510X(02)00343-X","article-title":"The role of intravenous immunoglobulin in the treatment of multiple sclerosis","volume":"206","author":"Sorensen","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clim.2006.01.003_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-4615-2427-4_14","article-title":"Naturally occurring human autoantibodies to defined T-cell receptor and light chain peptides","volume":"347","author":"Marchalonis","year":"1994","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.clim.2006.01.003_bib39","first-page":"193","article-title":"Natural autoantibodies to TCR public idiotopes: potential roles in immunomulation","volume":"49","author":"Schluter","year":"2003","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.clim.2006.01.003_bib40","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/blood.V100.5.1774.h81702001774_1774_1779","article-title":"Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis","volume":"100","author":"Mouzaki","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clim.2006.01.003_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0897.2003.01169.x","article-title":"Effect of intravenous immunoglobulin treatment on the Th1\/Th2 balance in women with recurrent spontaneous abortions","volume":"49","author":"Graphou","year":"2003","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib42","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/intimm\/7.8.1353","article-title":"Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response","volume":"7","author":"Liu","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib43","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/intimm\/13.12.1583","article-title":"Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations","volume":"13","author":"Rivera","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2006.01.003_bib44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.183.4.1339","article-title":"CD4+ T cells activation and tolerance induction in B cell knockout mice","volume":"183","author":"Phillips","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.01.003_bib45","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.182.4.915","article-title":"Successful T cell primming in B cell-deficient mice","volume":"182","author":"Epstein","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2006.01.003_bib46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/jaut.2000.0371","article-title":"Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice","volume":"14","author":"Dittel","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2006.01.003_bib47","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0264-410X(97)00054-6","article-title":"Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties","volume":"15","author":"Goto","year":"1997","journal-title":"Vaccine"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661606000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T16:54:03Z","timestamp":1683392043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661606000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1521661606000337"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2006.01.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}